ArticleRenal failure2024

Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study.

Aikeda Yimamuyushan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.